z-logo
open-access-imgOpen Access
Emergence of pan-resistance in KPC-2 carbapenemase-producingKlebsiella pneumoniaein Crete, Greece: a close call
Author(s) -
Erik Bathoorn,
Constantinos Tsioutis,
Júlia M. da Silva Voorham,
Effie Scoulica,
Eleni Ioannidou,
Kai Zhou,
John W. A. Rossen,
Achilleas Gikas,
Alex W. Friedrich,
Hajo Grundmann
Publication year - 2016
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkv467
Subject(s) - klebsiella pneumoniae , multilocus sequence typing , colistin , tigecycline , microbiology and biotechnology , antibiotics , antibiotic resistance , biology , gene , genetics , genotype , escherichia coli
KPC-2-producing Klebsiella pneumoniae (KPC-KP) ST258 has been rapidly expanding and is often associated with serious nosocomial infections. Last-line antibiotics such as colistin and tigecycline often remain the only treatment option. We describe here the evolving genetic background of KPC-KP isolates in Crete, Greece.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom